• Loading stock data...
Est. 2004

Sunday 02/17/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 4:39 PM

    MINNEAPOLIS , July 12, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that on July 11, 2018 the European Patent Office (“EPO”) granted European Patent No. 2948200  covering the Company’s STREAMWAY® System for automated, direct-to-drain medical fluid disposal, which is sold through the Company’s Skyline Medical division. The Company is seeking national validation of its European patent in 11 European countries, including

    Read more
  • 11:53 AM

    LAS VEGAS, NV / ACCESSWIRE / July 10, 2018 / Wrap Technologies, Inc. (OTCQB: WRTC), an innovator of modern policing solutions, today announced the granting of its first U.S. patent and recapped its intellectual property strategy. The Company recently secured its first U.S. patent on its BolaWrap remote restraint technology and has an additional seven U.S. patents pending. The Company has also filed to reserve all international patent rights to its BolaWrap innovations. The Company’s strategy is to protect and vigorously

    Read more
  • 6:15 PM

    Las Vegas, June 27, 2018 (GLOBE NEWSWIRE) — GB Sciences, Inc. (OTCQB: GBLX) has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of cannabis-sensitive ion channels in sensory neurons that contribute to chronic inflammatory pain conditions, peripheral neuropathy, urinary cystitis, asthma, and specific types of hearing loss. The GB Sciences drug development team believes that these new cannabis-based treatments could well herald the dawning of ‘individualized medicines’ from the cannabis plant by re-establishing

    Read more
  • 2:42 PM

    Cannabics patent granted with enabling technology to personalize Cannabinoid diagnostics and treatment for Cancer patients PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office of the State of Israel. The Patent Office intends to grant Cannabics the patent for its method of high throughput screening of

    Read more
  • 8:25 AM

    Cannabis Strategic Files Provision Patent for Unique Cannabis Smoke Filtration Device LOS ANGELES,March 21, 2018/PRNewswire/ — Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) today announces the filing of a new provisional patent in the booming cannabis sector. The technology covered under the provisional patent is for a unique and proprietary filtration product that significantly reduces heavy chemicals, tars and harsh tastes in cannabis smoke, while still preserving THC output and terpenes. Mr. Simon Yu, CEO of Cannabis Strategic Ventures, commented,

    Read more
  • 8:44 AM

    ORLANDO, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE– Immune Therapeutics, Inc. (OTCQB:IMUN) (“Immune” “IMUN” or the “Company”), a clinical late stage biopharmaceutical company focused on the development of two immunomodulating therapies (IRT-103 “Lodonal” and IRT-101 “MENK”) for the treatment of autoimmune diseases, inflammatory diseases, cancer and HIV/AIDs,  today announced the company has shipped its initial order of Lodonal to AHAR Pharma in Nigeria.  In addition, IMUN has received both trademark and patent approval from the Federal

    Read more
Public Wire Banner